240 related articles for article (PubMed ID: 21199807)
1. Plasminogen activator uPA is a direct transcriptional target of the JAG1-Notch receptor signaling pathway in breast cancer.
Shimizu M; Cohen B; Goldvasser P; Berman H; Virtanen C; Reedijk M
Cancer Res; 2011 Jan; 71(1):277-86. PubMed ID: 21199807
[TBL] [Abstract][Full Text] [Related]
2. Cyclin D1 is a direct target of JAG1-mediated Notch signaling in breast cancer.
Cohen B; Shimizu M; Izrailit J; Ng NF; Buchman Y; Pan JG; Dering J; Reedijk M
Breast Cancer Res Treat; 2010 Aug; 123(1):113-24. PubMed ID: 19915977
[TBL] [Abstract][Full Text] [Related]
3. Restored expression of the tumor suppressor gene RUNX3 reduces cancer stem cells in hepatocellular carcinoma by suppressing Jagged1-Notch signaling.
Nishina S; Shiraha H; Nakanishi Y; Tanaka S; Matsubara M; Takaoka N; Uemura M; Horiguchi S; Kataoka J; Iwamuro M; Yagi T; Yamamoto K
Oncol Rep; 2011 Sep; 26(3):523-31. PubMed ID: 21637926
[TBL] [Abstract][Full Text] [Related]
4. Specific knockdown of uPA/uPAR attenuates invasion in glioblastoma cells and xenografts by inhibition of cleavage and trafficking of Notch -1 receptor.
Raghu H; Gondi CS; Dinh DH; Gujrati M; Rao JS
Mol Cancer; 2011 Oct; 10():130. PubMed ID: 22004682
[TBL] [Abstract][Full Text] [Related]
5. Notch ligand, JAG1, is evolutionarily conserved target of canonical WNT signaling pathway in progenitor cells.
Katoh M; Katoh M
Int J Mol Med; 2006 Apr; 17(4):681-5. PubMed ID: 16525728
[TBL] [Abstract][Full Text] [Related]
6. Adrenergic signaling promotes angiogenesis through endothelial cell-tumor cell crosstalk.
Chen H; Liu D; Yang Z; Sun L; Deng Q; Yang S; Qian L; Guo L; Yu M; Hu M; Shi M; Guo N
Endocr Relat Cancer; 2014 Oct; 21(5):783-95. PubMed ID: 25179535
[TBL] [Abstract][Full Text] [Related]
7. Histone demethylase KDM4C regulates sphere formation by mediating the cross talk between Wnt and Notch pathways in colonic cancer cells.
Yamamoto S; Tateishi K; Kudo Y; Yamamoto K; Isagawa T; Nagae G; Nakatsuka T; Asaoka Y; Ijichi H; Hirata Y; Otsuka M; Ikenoue T; Aburatani H; Omata M; Koike K
Carcinogenesis; 2013 Oct; 34(10):2380-8. PubMed ID: 23698634
[TBL] [Abstract][Full Text] [Related]
8. BRCA1 is a key regulator of breast differentiation through activation of Notch signalling with implications for anti-endocrine treatment of breast cancers.
Buckley NE; Nic An tSaoir CB; Blayney JK; Oram LC; Crawford NT; D'Costa ZC; Quinn JE; Kennedy RD; Harkin DP; Mullan PB
Nucleic Acids Res; 2013 Oct; 41(18):8601-14. PubMed ID: 23863842
[TBL] [Abstract][Full Text] [Related]
9. Disrupting Jagged1-Notch signaling impairs spatial memory formation in adult mice.
Sargin D; Botly LC; Higgs G; Marsolais A; Frankland PW; Egan SE; Josselyn SA
Neurobiol Learn Mem; 2013 Jul; 103():39-49. PubMed ID: 23567106
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of Notch signalling molecules and their involvement in the invasiveness of endometrial carcinoma cells.
Mitsuhashi Y; Horiuchi A; Miyamoto T; Kashima H; Suzuki A; Shiozawa T
Histopathology; 2012 Apr; 60(5):826-37. PubMed ID: 22348356
[TBL] [Abstract][Full Text] [Related]
11. PKCα Attenuates Jagged-1-Mediated Notch Signaling in ErbB-2-Positive Breast Cancer to Reverse Trastuzumab Resistance.
Pandya K; Wyatt D; Gallagher B; Shah D; Baker A; Bloodworth J; Zlobin A; Pannuti A; Green A; Ellis IO; Filipovic A; Sagert J; Rana A; Albain KS; Miele L; Denning MF; Osipo C
Clin Cancer Res; 2016 Jan; 22(1):175-86. PubMed ID: 26350262
[TBL] [Abstract][Full Text] [Related]
12. JAG1 expression is associated with a basal phenotype and recurrence in lymph node-negative breast cancer.
Reedijk M; Pinnaduwage D; Dickson BC; Mulligan AM; Zhang H; Bull SB; O'Malley FP; Egan SE; Andrulis IL
Breast Cancer Res Treat; 2008 Oct; 111(3):439-48. PubMed ID: 17990101
[TBL] [Abstract][Full Text] [Related]
13. PKCδ is required for Jagged-1 induction of human mesenchymal stem cell osteogenic differentiation.
Zhu F; Sweetwyne MT; Hankenson KD
Stem Cells; 2013 Jun; 31(6):1181-92. PubMed ID: 23404789
[TBL] [Abstract][Full Text] [Related]
14. NF-κB non-cell-autonomously regulates cancer stem cell populations in the basal-like breast cancer subtype.
Yamamoto M; Taguchi Y; Ito-Kureha T; Semba K; Yamaguchi N; Inoue J
Nat Commun; 2013; 4():2299. PubMed ID: 23934482
[TBL] [Abstract][Full Text] [Related]
15. NOTCH ligands JAG1 and JAG2 as critical pro-survival factors in childhood medulloblastoma.
Fiaschetti G; Schroeder C; Castelletti D; Arcaro A; Westermann F; Baumgartner M; Shalaby T; Grotzer MA
Acta Neuropathol Commun; 2014 Apr; 2():39. PubMed ID: 24708907
[TBL] [Abstract][Full Text] [Related]
16. Ligand-dependent Notch signaling strength orchestrates lateral induction and lateral inhibition in the developing inner ear.
Petrovic J; Formosa-Jordan P; Luna-Escalante JC; Abelló G; Ibañes M; Neves J; Giraldez F
Development; 2014 Jun; 141(11):2313-24. PubMed ID: 24821984
[TBL] [Abstract][Full Text] [Related]
17. Regulatory interplay between miR-21, JAG1 and 17beta-estradiol (E2) in breast cancer cells.
Selcuklu SD; Donoghue MT; Kerin MJ; Spillane C
Biochem Biophys Res Commun; 2012 Jun; 423(2):234-9. PubMed ID: 22618231
[TBL] [Abstract][Full Text] [Related]
18. A study on Notch signaling in human breast cancer.
Zang S; Ji Ch; Qu X; Dong X; Ma D; Ye J; Ma R; Dai J; Guo D
Neoplasma; 2007; 54(4):304-10. PubMed ID: 17822320
[TBL] [Abstract][Full Text] [Related]
19. Calcitonin inhibits invasion of breast cancer cells: involvement of urokinase-type plasminogen activator (uPA) and uPA receptor.
Han B; Nakamura M; Zhou G; Ishii A; Nakamura A; Bai Y; Mori I; Kakudo K
Int J Oncol; 2006 Apr; 28(4):807-14. PubMed ID: 16525628
[TBL] [Abstract][Full Text] [Related]
20. Platelet-derived growth factor-D contributes to aggressiveness of breast cancer cells by up-regulating Notch and NF-κB signaling pathways.
Ahmad A; Wang Z; Kong D; Ali R; Ali S; Banerjee S; Sarkar FH
Breast Cancer Res Treat; 2011 Feb; 126(1):15-25. PubMed ID: 20379844
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
